$XWEL
XWELL Inc Stock $xwel

$xwel Overview Financials Valuation SEC Filings Company Website

2012 Q2 Form 10-Q Financial Statement

#000114420413043978 Filed on August 08, 2013

Income Statement

Concept	2012 Q2
Revenue	$100.0K
YoY Change	-55.95%
Cost Of Revenue	$31.00K
YoY Change	-31.11%
Gross Profit	$69.00K
YoY Change	-62.09%
Gross Profit Margin	69.0%
Selling, General & Admin	$1.622M
YoY Change	17.96%
% of Gross Profit	2350.72%
Research & Development	$418.0K
YoY Change	-9.13%
% of Gross Profit	605.8%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.040M
YoY Change	11.17%
Operating Profit	-$1.971M
YoY Change	19.24%
Interest Expense	$0.00
YoY Change	-100.0%
% of Operating Profit
Other Income/Expense, Net	$0.00
YoY Change	-100.0%
Pretax Income	-$5.086M
YoY Change	244.11%
Income Tax	$83.00K
% Of Pretax Income
Net Earnings	-$5.169M
YoY Change	243.68%
Net Earnings / Revenue	-5169.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$92.00M
COMMON SHARES
Basic Shares Outstanding	14.70M shares
Diluted Shares Outstanding	14.70M shares

Balance Sheet

Concept	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.400M
YoY Change	750.0%
Cash & Equivalents	$2.571M
Short-Term Investments
Other Short-Term Assets	$100.0K
YoY Change	-92.31%
Inventory
Prepaid Expenses
Receivables	$126.0K
Other Receivables	$0.00
Total Short-Term Assets	$3.606M
YoY Change	89.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$121.0K
YoY Change	-39.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$129.0K
YoY Change	-35.5%
TOTAL ASSETS
Total Short-Term Assets	$3.606M
Total Long-Term Assets	$129.0K
Total Assets	$3.735M
YoY Change	77.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.000M
YoY Change	150.0%
Accrued Expenses	$300.0K
YoY Change	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$200.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.552M
YoY Change	-18.32%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$3.600M
YoY Change	89.47%
Total Long-Term Liabilities	$3.555M
YoY Change	87.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.552M
Total Long-Term Liabilities	$3.555M
Total Liabilities	$5.107M
YoY Change	34.39%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$151.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.372M
YoY Change
Total Liabilities & Shareholders Equity	$3.735M
YoY Change	77.86%

Cashflow Statement

Concept	2012 Q2
OPERATING ACTIVITIES
Net Income	-$5.169M
YoY Change	243.68%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.400M
YoY Change	0.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-1.400M
Cash From Investing Activities	0.000
Cash From Financing Activities	0.000
Net Change In Cash	-1.400M
YoY Change	-55.56%
FREE CASH FLOW
Cash From Operating Activities	-$1.400M
Capital Expenditures	$0.00
Free Cash Flow	-$1.400M
YoY Change	1.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82957670	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82957670	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81889226	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81889226	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82739447	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14700170	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82552710	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13844037	shares
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1868000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2883000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-4000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-12000	USD
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	-73000	USD
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	-7000	USD
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	161000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1412000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	593000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43125201	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82739447	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14700170	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82552710	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13844037	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41709963	shares
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3022000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	85000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6116000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	169000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2754000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	2865000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-20841000	USD
CY2012	vrng	Adjustments To Additional Paid In Capital Warrant Exercised AdjustmentsToAdditionalPaidInCapitalWarrantExercised	22932000	USD
	vrng	Adjustments To Additional Paid In Capital Warrant Exercised AdjustmentsToAdditionalPaidInCapitalWarrantExercised	250000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	509000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	153000	USD
CY2012	vrng	Adjustment To Additonal Paid In Capital Issuance Of Shares In Financing Round Two AdjustmentToAdditonalPaidInCapitalIssuanceOfSharesInFinancingRoundTwo	44962000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8087000	USD
CY2012	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	54961000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2883000	USD
CY2012	vrng	Adjustment To Additonal Paid In Capital Issuance Of Shares In Financing Round One AdjustmentToAdditonalPaidInCapitalIssuanceOfSharesInFinancingRoundOne	31148000	USD
CY2012	vrng	Stock Issued During Period For Patents StockIssuedDuringPeriodForPatents	750000	USD
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	76000	USD
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
	vrng	Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants	3748000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2567000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	313000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5397000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-58000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6116000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	169000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14677000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	248000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3120000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3120000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25944000	USD
	us-gaap	Payments For Deposits PaymentsForDeposits	-8000	USD
	us-gaap	Payments For Deposits PaymentsForDeposits	0	USD
	us-gaap	Payments For Deposits PaymentsForDeposits	38000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3326000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3143000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26024000	USD
	vrng	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	0	USD
	vrng	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	0	USD
	vrng	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	31148000	USD
	vrng	Proceeds From Issuance Of Common Stock Two ProceedsFromIssuanceOfCommonStockTwo	0	USD
	vrng	Proceeds From Issuance Of Common Stock Two ProceedsFromIssuanceOfCommonStockTwo	0	USD
	vrng	Proceeds From Issuance Of Common Stock Two ProceedsFromIssuanceOfCommonStockTwo	44962000	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
	vrng	Proceeds From Mezzanine Preferred Stock ProceedsFromMezzaninePreferredStock	0	USD
	vrng	Proceeds From Mezzanine Preferred Stock ProceedsFromMezzaninePreferredStock	0	USD
	vrng	Proceeds From Mezzanine Preferred Stock ProceedsFromMezzaninePreferredStock	1800000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5145000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	153000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	662000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	174000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	12449000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	327000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	96166000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	10000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	8000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-13772000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2641000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	43188000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5212000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2571000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	4000	USD
	us-gaap	Interest Paid InterestPaid	17000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	39000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	39000	USD
	vrng	Conversion Of Derivative Warrant ConversionOfDerivativeWarrant	76000	USD
	vrng	Conversion Of Derivative Warrant ConversionOfDerivativeWarrant	0	USD
	vrng	Conversion Of Derivative Warrant ConversionOfDerivativeWarrant	10733000	USD
	vrng	Purchase Patents PurchasePatents	0	USD
	vrng	Purchase Patents PurchasePatents	0	USD
	vrng	Purchase Patents PurchasePatents	750000	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	0	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	76000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1724000	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	0	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	0	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	201000	USD
	vrng	Noncash Or Part Noncash Acquisition Working Capital Acquired NoncashOrPartNoncashAcquisitionWorkingCapitalAcquired	740000	USD
	vrng	Noncash Or Part Noncash Acquisition Long Term Deposit Acquired NoncashOrPartNoncashAcquisitionLongTermDepositAcquired	-8000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	124000	USD
	vrng	Noncash Or Part Noncash Acquisition Goodwill Acquired NoncashOrPartNoncashAcquisitionGoodwillAcquired	-65965000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	10133000	USD
	vrng	Noncash Or Part Noncash Acquisition Fair Value Of Common Stock Acquired NoncashOrPartNoncashAcquisitionFairValueOfCommonStockAcquired	58211000	USD
	vrng	Noncash Or Part Noncash Acquisition Fair Value Of Warrants Acquired NoncashOrPartNoncashAcquisitionFairValueOfWarrantsAcquired	17443000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	3162000	USD
	vrng	Total Cash Acquired During Acqusition TotalCashAcquiredDuringAcqusition	3326000	USD
	vrng	Assignment Of Patents AssignmentOfPatents	100000	USD
	vrng	Assignment Of Patents AssignmentOfPatents	0	USD
	vrng	Assignment Of Patents AssignmentOfPatents	100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10966000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2630000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26962000	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	0	USD
	vrng	Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants	0	USD
	vrng	Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants	3748000	USD
	vrng	Percentage Of Interest Owned Reverse Acquisition Transaction PercentageOfInterestOwnedReverseAcquisitionTransaction	0.6761	pure
	us-gaap	Nature Of Operations NatureOfOperations	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <font style="BACKGROUND-COLOR: transparent"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent"><font size="2"><strong style="TEXT-INDENT: 0in; MARGIN: 0in"><font style="BACKGROUND-COLOR: transparent">Note 1. General</font></strong></font></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="BACKGROUND-COLOR: transparent"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="BACKGROUND-COLOR: transparent"><font style="BACKGROUND-COLOR: transparent">Vringo, Inc., together with its consolidated subsidiaries (the “Company”), is engaged in the development and <font style="BACKGROUND-COLOR: transparent"> monetization</font> of intellectual property worldwide.  The Company's intellectual property portfolio consists of over 500 patents and patent applications covering telecom infrastructure, internet search and mobile technologies. The Company’s patents and patent applications have been developed internally and acquired from third parties. The Company operates a global platform for the distribution of mobile social applications and services it develops.</font></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="BACKGROUND-COLOR: transparent"><font style="BACKGROUND-COLOR: transparent"> </font></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="BACKGROUND-COLOR: transparent"><font style="BACKGROUND-COLOR: transparent">On July 19, 2012, Vringo, Inc., a Delaware corporation (“Vringo” or “Legal Parent”), closed a merger transaction (the “Merger”) with Innovate/Protect, Inc., a privately held Delaware corporation (“I/P”), pursuant to an Agreement and Plan of Merger, dated as of March 13, 2012 (the “Merger Agreement”), by and among Vringo, I/P and VIP Merger Sub, Inc., a wholly-owned subsidiary of Vringo (“Merger Sub”). Pursuant to the Merger Agreement, I/P became a wholly-owned subsidiary of Vringo through a merger of I/P with and into Merger Sub, and the former stockholders of I/P received shares of Vringo that constituted a majority of the outstanding shares of Vringo.</font></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="BACKGROUND-COLOR: transparent"><font style="BACKGROUND-COLOR: transparent"> </font></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="BACKGROUND-COLOR: transparent"><font style="BACKGROUND-COLOR: transparent">Immediately following the Merger, approximately <font style=" FONT-SIZE: 10pt">67.61</font>% of the combined company was owned by I/P stockholders on a fully diluted basis, and as a result of this and other factors, I/P was deemed to be the acquiring company for accounting purposes and the transaction was accounted for as a reverse acquisition in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Accordingly, the Company’s financial statements for periods prior to the Merger reflect the historical results of I/P and not Legal Parent<font style="BACKGROUND-COLOR: transparent">’</font>s historical results prior to the Merger, and the Company’s financial statements for all periods from July 19, 2012 reflect the results of the combined company. Unless specifically noted otherwise, as used throughout these consolidated financial statements, the term “Company” refers to the combined company after the Merger and the business of I/P before the Merger. The terms I/P and Vringo or Legal Parent refer to such entities’ standalone businesses prior to the Merger.</font></font></div> </div>
CY2012Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	14700170	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	82406883	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	13844037	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	41596664	shares
CY2013Q2	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	114152	shares
CY2012Q2	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	0	shares
	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	145827	shares
	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	0	shares
	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	113299	shares
CY2013Q2	vrng	Incremental Net Income Loss Available To Series1 Warrents Diluted IncrementalNetIncomeLossAvailableToSeries1WarrentsDiluted	0	USD
CY2012Q2	vrng	Incremental Net Income Loss Available To Series1 Warrents Diluted IncrementalNetIncomeLossAvailableToSeries1WarrentsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Series1 Warrents Diluted IncrementalNetIncomeLossAvailableToSeries1WarrentsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Series1 Warrents Diluted IncrementalNetIncomeLossAvailableToSeries1WarrentsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Series1 Warrents Diluted IncrementalNetIncomeLossAvailableToSeries1WarrentsDiluted	2482000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>(d) Use of estimates</em></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include valuation of assets assumed and liabilities incurred as part of the Merger, useful lives of the Company’s tangible and intangible assets, valuation of its October 2012 Warrants (as such term is defined below) and derivative warrants, valuation of its s tock-based compensation, deferred tax assets and liabilities, income tax uncertainties and other contingencies.</div> </div>
CY2013Q2	vrng	Incremental Net Income Loss Available To Preferential Reload Warrants Diluted IncrementalNetIncomeLossAvailableToPreferentialReloadWarrantsDiluted	0	USD
CY2012Q2	vrng	Incremental Net Income Loss Available To Preferential Reload Warrants Diluted IncrementalNetIncomeLossAvailableToPreferentialReloadWarrantsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Preferential Reload Warrants Diluted IncrementalNetIncomeLossAvailableToPreferentialReloadWarrantsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Preferential Reload Warrants Diluted IncrementalNetIncomeLossAvailableToPreferentialReloadWarrantsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Preferential Reload Warrants Diluted IncrementalNetIncomeLossAvailableToPreferentialReloadWarrantsDiluted	135000	USD
CY2013Q2	vrng	Incremental Net Income Loss Available To Conversion Warrants Diluted IncrementalNetIncomeLossAvailableToConversionWarrantsDiluted	0	USD
CY2012Q2	vrng	Incremental Net Income Loss Available To Conversion Warrants Diluted IncrementalNetIncomeLossAvailableToConversionWarrantsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Conversion Warrants Diluted IncrementalNetIncomeLossAvailableToConversionWarrantsDiluted	0	USD
CY2012Q2	vrng	Incremental Net Income Loss Available To Special Bridge Warrants Diluted IncrementalNetIncomeLossAvailableToSpecialBridgeWarrantsDiluted	0	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>(j) Reclassification</em></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Certain comparative amounts were reclassified to conform to the Company’s post-Merger presentation.</div> </div>
CY2013Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	82625295	shares
	vrng	Incremental Net Income Loss Available To Conversion Warrants Diluted IncrementalNetIncomeLossAvailableToConversionWarrantsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Conversion Warrants Diluted IncrementalNetIncomeLossAvailableToConversionWarrantsDiluted	68000	USD
CY2013Q2	vrng	Incremental Net Income Loss Available To Special Bridge Warrants Diluted IncrementalNetIncomeLossAvailableToSpecialBridgeWarrantsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Special Bridge Warrants Diluted IncrementalNetIncomeLossAvailableToSpecialBridgeWarrantsDiluted	0	USD
	vrng	Incremental Net Income Loss Available To Special Bridge Warrants Diluted IncrementalNetIncomeLossAvailableToSpecialBridgeWarrantsDiluted	0	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	156000	USD
	vrng	Incremental Net Income Loss Available To Special Bridge Warrants Diluted IncrementalNetIncomeLossAvailableToSpecialBridgeWarrantsDiluted	100000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10940000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1841000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22904000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3712000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-49284000	USD
CY2013Q2	vrng	Weighted Average Number Of Series1 Warrants Issued Diluted WeightedAverageNumberOfSeries1WarrantsIssuedDiluted	0	shares
CY2012Q2	vrng	Weighted Average Number Of Series1 Warrants Issued Diluted WeightedAverageNumberOfSeries1WarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Series1 Warrants Issued Diluted WeightedAverageNumberOfSeries1WarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Series1 Warrants Issued Diluted WeightedAverageNumberOfSeries1WarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Series1 Warrants Issued Diluted WeightedAverageNumberOfSeries1WarrantsIssuedDiluted	1223067	shares
CY2013Q2	vrng	Weighted Average Number Of Preferential Reload Warrants Issued Diluted WeightedAverageNumberOfPreferentialReloadWarrantsIssuedDiluted	0	shares
CY2012Q2	vrng	Weighted Average Number Of Preferential Reload Warrants Issued Diluted WeightedAverageNumberOfPreferentialReloadWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Preferential Reload Warrants Issued Diluted WeightedAverageNumberOfPreferentialReloadWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Preferential Reload Warrants Issued Diluted WeightedAverageNumberOfPreferentialReloadWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Preferential Reload Warrants Issued Diluted WeightedAverageNumberOfPreferentialReloadWarrantsIssuedDiluted	75197	shares
CY2013Q2	vrng	Weighted Average Number Of Conversion Warrants Issued Diluted WeightedAverageNumberOfConversionWarrantsIssuedDiluted	0	shares
CY2012Q2	vrng	Weighted Average Number Of Conversion Warrants Issued Diluted WeightedAverageNumberOfConversionWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Conversion Warrants Issued Diluted WeightedAverageNumberOfConversionWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Conversion Warrants Issued Diluted WeightedAverageNumberOfConversionWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Conversion Warrants Issued Diluted WeightedAverageNumberOfConversionWarrantsIssuedDiluted	47497	shares
CY2013Q2	vrng	Weighted Average Number Of Special Bridge Warrants Issued Diluted WeightedAverageNumberOfSpecialBridgeWarrantsIssuedDiluted	0	shares
CY2012Q2	vrng	Weighted Average Number Of Special Bridge Warrants Issued Diluted WeightedAverageNumberOfSpecialBridgeWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Special Bridge Warrants Issued Diluted WeightedAverageNumberOfSpecialBridgeWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Special Bridge Warrants Issued Diluted WeightedAverageNumberOfSpecialBridgeWarrantsIssuedDiluted	0	shares
	vrng	Weighted Average Number Of Special Bridge Warrants Issued Diluted WeightedAverageNumberOfSpecialBridgeWarrantsIssuedDiluted	69477	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33449701	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3580790	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33449701	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3580790	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29910279	shares
CY2012Q3	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	22000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36927000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36827000	USD
CY2012	vrng	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Derivative Warrants Issued By Legal Parent FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityDerivativeWarrantsIssuedByLegalParent	3162000	USD
CY2013Q2	vrng	Business Acquisition Purchases Price Allocation Assets Acquired Liabilities Assumed Net BusinessAcquisitionPurchasesPriceAllocationAssetsAcquiredLiabilitiesAssumedNet	75654000	USD
CY2012Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	20136445	shares
	vrng	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	99147	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	969297	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9149105	shares
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31629000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5298000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2783000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	34044000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2489000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5009000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5009000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4618000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	14504000	USD
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	vrng	Fair Value Inputs Probability Of Achieving Target FairValueInputsProbabilityOfAchievingTarget	0.15	pure
	vrng	Fair Value Assumptions Timing Of Down Round Triggering Event FairValueAssumptionsTimingOfDownRoundTriggeringEvent	December 2013
CY2013Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	5655000	USD
CY2012Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	7612000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7612000	USD
CY2012	vrng	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Recorded In Connection With Merger FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRecordedInConnectionWithMerger	21954000	USD
CY2012	vrng	Fair Value Measurement Adjusted In Earnings FairValueMeasurementAdjustedInEarnings	-7003000	USD
	vrng	Fair Value Measurement Adjusted In Earnings FairValueMeasurementAdjustedInEarnings	318000	USD
CY2012	vrng	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Derivative Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfDerivativeWarrants	10657000	USD
	vrng	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Derivative Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfDerivativeWarrants	76000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2013Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5655000	USD
	vrng	Fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityderivativewarrantsremoval Fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityderivativewarrantsremoval	-2174000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-25000	USD
CY2012Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	6673	shares
CY2012Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	463000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3198333	shares
	vrng	Share Based Compensation Arrangement Award Options Exercised ShareBasedCompensationArrangementAwardOptionsExercised	178967	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18863261	shares
CY2013Q2	vrng	Business Acquisition Purchases Price Allocation Current Assets BusinessAcquisitionPurchasesPriceAllocationCurrentAssets	2586000	USD
CY2013Q2	vrng	Business Acquisition Purchases Price Allocation Property Plant And Equipment BusinessAcquisitionPurchasesPriceAllocationPropertyPlantAndEquipment	124000	USD
CY2013Q2	vrng	Business Acquisition Purchase Price Allocation Current Assets Net Of Current Liability BusinessAcquisitionPurchasePriceAllocationCurrentAssetsNetOfCurrentLiability	8000	USD
CY2013Q2	vrng	Business Acquisition Purchases Price Allocation Goodwill Amount BusinessAcquisitionPurchasesPriceAllocationGoodwillAmount	65965000	USD
CY2013Q2	vrng	Business Acquisition Purchase Price Allocation Technology BusinessAcquisitionPurchasePriceAllocationTechnology	-10133000	USD
CY2013Q2	vrng	Business Acquisition Purchases Price Allocation Assets Acquired BusinessAcquisitionPurchasesPriceAllocationAssetsAcquired	78816000	USD
CY2013Q2	vrng	Business Acquisition Purchases Price Allocation Noncurrent Liabilities Long Term Debt BusinessAcquisitionPurchasesPriceAllocationNoncurrentLiabilitiesLongTermDebt	3162000	USD
CY2013Q2	vrng	Business Acquisition Purchases Price Allocation Liabilities Assumed BusinessAcquisitionPurchasesPriceAllocationLiabilitiesAssumed	3162000	USD
CY2013Q2	vrng	Business Acquisition Purchase Price Allocation Fair Value Of Vested Stock Options Granted To Employees Management And Consultants BusinessAcquisitionPurchasePriceAllocationFairValueOfVestedStockOptionsGrantedToEmployeesManagementAndConsultants	-7364000	USD
CY2013Q2	vrng	Business Acquisition Purchase Price Allocation Fair Value Of Outstanding Warrants Granted By Legal Parent Prior To Merger BusinessAcquisitionPurchasePriceAllocationFairValueOfOutstandingWarrantsGrantedByLegalParentPriorToMerger	-10079000	USD
CY2013Q2	vrng	Business Acquisition Purchase Price Allocation Fair Value Of Vringo Shares Of Common Stock And Vested Options Granted To Employees Management And Consultants BusinessAcquisitionPurchasePriceAllocationFairValueOfVringoSharesOfCommonStockAndVestedOptionsGrantedToEmployeesManagementAndConsultants	-58211000	USD
CY2013Q2	vrng	Business Acquisitions Cost Of Acquired Entity Purchase Price BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice	75654000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	206000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2235000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-64914000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-15369000	USD
CY2012Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	100000	USD
CY2012Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-7430000	USD
CY2012	vrng	Class Of Warrant Or Right Exercise ClassOfWarrantOrRightExercise	250000000	shares
CY2012Q4	vrng	Expected Term Of Warrants ExpectedTermOfWarrants	P2Y7M28D
	vrng	Class Of Warrant Or Right Exercises In Period Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisesInPeriodExercisePriceOfWarrantsOrRights	1.76
CY2011Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	8768014	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16972977	shares
CY2012	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	890192	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	265000	shares
CY2012	vrng	Legal Parents Shares Of Common Stock Recorded Upon Merger LegalParentsSharesOfCommonStockRecordedUponMerger	15206118	shares
CY2012	vrng	Waarrants Issued And Exercised WaarrantsIssuedAndExercised	754400	shares
CY2012	vrng	Waarrants Issued And Exercised Before Merger WaarrantsIssuedAndExercisedBeforeMerger	6832150	shares
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	726346	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18764114	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11916692	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5706237	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.47
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	232404	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	19375	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.23
	vrng	Share Based Compensation Arrangement Award Equity Instruments Other Than Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue	3.23
	vrng	Share Based Compensation Arrangement Award Equity Instruments Other Than Options Expired At Merger Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementAwardEquityInstrumentsOtherThanOptionsExpiredAtMergerWeightedAverageGrantDateFairValue	2.40
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.28
CY2013Q2	us-gaap	Litigation Reserve LitigationReserve	2900000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	107000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	22000	USD
CY2013Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	63000	USD
CY2012Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	14000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	238000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	121000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	199000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	124000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	449000	USD

Files In Submission

Name	View Source	Status
0001144204-13-043978-index-headers.html	Edgar Link	pending
0001144204-13-043978-index.html	Edgar Link	pending
0001144204-13-043978.txt	Edgar Link	pending
0001144204-13-043978-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v350333_10q.htm	Edgar Link	pending
v350333_ex31-1.htm	Edgar Link	pending
v350333_ex31-2.htm	Edgar Link	pending
v350333_ex32-1.htm	Edgar Link	pending
v350333_ex32-2.htm	Edgar Link	pending
vrng-20130630.xml	Edgar Link	completed
vrng-20130630.xsd	Edgar Link	pending
vrng-20130630_cal.xml	Edgar Link	unprocessable
vrng-20130630_def.xml	Edgar Link	unprocessable
vrng-20130630_lab.xml	Edgar Link	unprocessable
vrng-20130630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XWEL
XWELL Inc Stock $xwel

2012 Q2 Form 10-Q Financial Statement

#000114420413043978 Filed on August 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XWEL XWELL Inc Stock $xwel

2012 Q2 Form 10-Q Financial Statement

#000114420413043978 Filed on August 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XWEL
XWELL Inc Stock $xwel